Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • skbrimer
    Member
    • Mar 2014
    • 55

    #1

    Sample input vs genome length or both?

    Hellos group,

    I have a technical question, I'm working with a viral (surprise!) genome. It is approx 200kbp in length and is a DNA virus. We will be sequencing this on the Ion PGM and I have a question about library prep.

    We will be using the enzymatic shearing protocol which is optimized for e.coli which is 4.6 - 5.6 Mbp so I need to optimize the shear times. So my question is which is the more important factor to start tweaking, the amount of time spent in the reaction or the amount of enzyme used?

    Has anyone had any experience with this type of question I would like to know some of the pitfalls before I start burning through sample preps like a mad man.
  • lorendarith

    #2
    Is the enzymatic fragmentation done with transposomes or "randomly" cutting dsDNA endonucleases?

    I'd imagine the enzyme concentration having a higher impact than adjusting incubation times. See these two dsDNA shearases:
    Science made simple. Zymo Research provides products and services for molecular and cellular biology, Epigenetics and Microbiomics research. Try free sample kits today.



    Not sure what the difference between the "plus" and the "normal" version is (probably old and newer version), but in the "plus" one the sheared DNA exhibits clearer shifts with increasing units of enzyme added. Although that makes the price per reaction also higher.

    We also had this optimization in our lab, but I can't find the gel picture atm.

    Although these reactions are mostly optimized on humans or E.coli as you say, the DNA it is usually tested on is rarely bigger than the size of your intact viral genome. This heavily depends on the DNA prep. I wouldn't expect a drastically different shearing outcome...

    Comment

    • skbrimer
      Member
      • Mar 2014
      • 55

      #3
      Thank you lorendarith,

      These links are helpful and will give me a narrow window to try

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...